Synonyms:14C radioisotope;C-14 radioisotope;Carbon-14
The research focuses on the carbon-14 radiosynthesis of combretastatin A-1 (CA1) and its phosphate prodrug CA1P, which are derived from the African bush willow tree and have significant medicinal value due to their ability to inhibit tubulin assembly and act as vascular disrupting agents in cancer treatment. The study details a four-step synthesis process to incorporate carbon-14 into CA1 and CA1P with high specific activity. Key reactants include the CA1 precursor, [14C]methyl iodide for radiolabeling, TiCl4 for deprotection, and dibenzyl phosphite for phosphorylation. The methodology involves methylation of the C-4 protected phenolic moiety, de-isopropylation with TiCl4, and conversion to the phosphate prodrug. Analyses were performed using 1H NMR, analytical HPLC, and radio-TLC to ensure chemical and radiochemical purities, with the final product achieving a specific activity of 55 mCi/mmol.
Molahlehi S. Sonopo et al. present the synthesis and biological evaluation of a carbon-14-labeled pyrazole compound (11) as a potential anti-tuberculosis (TB) drug. The study involved a five-step synthesis process yielding compound 11 with a specific activity of 2242.4 MBq/mmol and a radiochemical purity of over 99%. Tissue distribution studies in both healthy and TB-infected mice revealed high accumulation of the compound in the small intestine, large intestine, and liver, suggesting hepatobiliary clearance. However, the compound showed no affinity for TB cells, indicating that it does not specifically target TB-infected tissues. This finding highlights the importance of early biodistribution studies in the drug discovery process to understand the in vivo behavior of potential therapeutic compounds.
What can I do for you?
Get Best Price
Total 8 Pictures about this product
